Alliance A221505: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation With Breast Reconstruction

Objective

This randomized phase III trial studies how well hypofractionated radiation therapy works in preventing recurrence in patients with stage IIa-IIIa cancer who have undergone mastectomy. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells that remain after surgery and have fewer side effects.

https://clinicaltrials.gov/ct2/show/NCT03414970

Location: Essentia Health Cancer Centers

Research Study Categories

  • Adult Studies

Specialty

  • Breast Cancer
Contact
Cancer Clinical Trials at 218-786-3308
or cancertrials@essentiahelath.org

Like most websites, we use cookies and other technologies to keep our website reliable, secure, and to better understand how our site is used. By using our site, you agree to our use of these tools. Learn more.